SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,422,833 | +69.3% | 51,608 | +84.6% | 0.79% | +63.6% |
| Q2 2023 | $840,237 | -24.2% | 27,952 | -8.6% | 0.48% | -28.1% |
| Q1 2023 | $1,107,805 | -5.4% | 30,577 | -6.9% | 0.67% | -11.9% |
| Q4 2022 | $1,171,367 | +4.1% | 32,839 | -1.2% | 0.76% | -6.0% |
| Q3 2022 | $1,125,000 | +4.4% | 33,244 | -10.9% | 0.81% | +10.6% |
| Q2 2022 | $1,078,000 | -12.1% | 37,294 | -1.8% | 0.74% | +5.9% |
| Q1 2022 | $1,227,000 | +12.4% | 37,969 | +1.3% | 0.69% | +30.5% |
| Q4 2021 | $1,092,000 | – | 37,481 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |